Organogenesis Holdings Inc

Freedman’s Dual Play: Organogenesis COO Locks In Future Gains While Trimming Current Holdings in Latest Insider Deal Flash.

Freedman Lori’s February 2026 trades at Organogenesis reveal a blend of RSU grants, share purchases, and modest sales, signaling long‑term confidence while maintaining liquidity for investors.

Organogenesis Holdings Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

20/02/2026, 23:44

5 minutes to read

Insider Surge: Organogenesis Executives Dump 400,000+ Shares in One Day, CFO Sells 53,000 Shares at $3.73, Hinting at Management Worry about Future Value

Insider selling spikes at Organogenesis Holdings – CFO and top execs sell 400k+ shares, hinting at doubts over future prospects and potential price correction.

Organogenesis Holdings Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

18/02/2026, 23:16

4 minutes to read